Page last updated: 2024-11-04

vorinostat and Deaf Mutism

vorinostat has been researched along with Deaf Mutism in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
" Heterozygous deletion of this alternative exon of mouse Rest causes hair cell degeneration and deafness, and the HDAC inhibitor SAHA (Vorinostat) rescues the hearing of these mice."3.88Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness. ( Bánfi, B; Boger, ET; Friedman, TB; Kelley, MW; Kelly, MC; Morell, RJ; Nakano, Y; Rehman, AU, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakano, Y1
Kelly, MC1
Rehman, AU1
Boger, ET1
Morell, RJ1
Kelley, MW1
Friedman, TB1
Bánfi, B1

Other Studies

1 other study available for vorinostat and Deaf Mutism

ArticleYear
Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness.
    Cell, 2018, 07-26, Volume: 174, Issue:3

    Topics: Alternative Splicing; Animals; Cell Line; Deafness; Exons; Gene Expression Regulation; Hair Cells, A

2018